Literature DB >> 14511461

Generation and characterization of recombinant unmodified and phosphorylatable murine IFN-alpha1 in the methylotropic yeast Pichia pastoris.

S Trajanovska1, C M Owczarek, P G Stanton, P J Hertzog.   

Abstract

In order to generate reagents to study the murine type I interferon (IFN) system, recombinant murine IFN-alpha1 (rMuIFN-alpha1) protein was expressed in the methylotropic yeast Pichia pastoris. rMuIFN-alpha1 with a phosphate acceptor site engineered at the C-terminus (rMuIFN-alpha1P) to enable radiolabeling by gamma(32)P-ATP and cAMP-dependent protein kinase was also generated. Proteins of 20, 25 (MuIFN-alpha1) and 25.5 (MuIFN-alpha1P), kDa were detected in the yeast growth medium, had type I IFN activity, and were recognized by antimurine L929 cell IFN antibodies. The MuIFN-alpha1 proteins produced in P. pastoris were a mixture of glycosylated and unglycosylated forms, with sugars of approximately 5 kDa added via N-linked glycosylation. The recombinant proteins were highly purified using a single RP-HPLC elution step, and their authenticity was confirmed by amino-terminal amino acid sequencing. The MuIFN-alpha1 and MuIFN-alpha1P protein preparations had specific antiviral activities of 1.3 x 10(7) and 4.7 x 10(6) IU/mg protein, respectively. MuIFN-alpha1P could be radiolabeled to a high specific radioactivity (0.6-2 x 10(8) cpm/microg protein) with gamma(32)P-ATP and cAMP-dependent protein kinase without significantly altering its biologic activity or electrophoretic properties. Binding experiments on COS-7 cells transiently transfected with MuIFNAR-2 and IFNAR-2 demonstrated specific and dose-dependent binding of gamma(32)P-ATP-MuIFN-alpha1P to cell surface type I IFN receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14511461     DOI: 10.1089/107999003322226005

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  3 in total

1.  Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2.

Authors:  Rebecca A R Piganis; Nicole A De Weerd; Jodee A Gould; Christian W Schindler; Ashley Mansell; Sandra E Nicholson; Paul J Hertzog
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

2.  Defining the distinct, intrinsic properties of the novel type I interferon, IFNϵ.

Authors:  Sebastian A Stifter; Antony Y Matthews; Niamh E Mangan; Ka Yee Fung; Alexander Drew; Michelle D Tate; Tatiana P Soares da Costa; Daniel Hampsey; Jemma Mayall; Phil M Hansbro; Albert Garcia Minambres; Sahar G Eid; Johnson Mak; Judy Scoble; George Lovrecz; Nicole A deWeerd; Paul J Hertzog
Journal:  J Biol Chem       Date:  2017-11-29       Impact factor: 5.157

3.  Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1.

Authors:  Nicole A de Weerd; Julian P Vivian; Thao K Nguyen; Niamh E Mangan; Jodee A Gould; Susie-Jane Braniff; Leyla Zaker-Tabrizi; Ka Yee Fung; Samuel C Forster; Travis Beddoe; Hugh H Reid; Jamie Rossjohn; Paul J Hertzog
Journal:  Nat Immunol       Date:  2013-07-21       Impact factor: 25.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.